Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
Together, Certara and our partners provide customers across the globe with products, services and solutions that help solve the key challenges of modern drug discovery and development.
Working in close partnership with respected scientists at designated academic Centers of Excellence, Certara is committed to training the next generation of experts in model-based techniques.
Certara works closely with scientific partners and collaborators to ensure that leading-edge technologies are delivered to customers.
Certara's technology & platform partners are companies that offer complementary products and platforms. Many of these are market leaders in their field and create stable, proven environments for developing and delivering Certara's solutions to our customers.
Certara has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration (FDA) to further develop the Simcyp Dog model for the evaluation of drug products intended for use in different canine breeds.